2 things of interest to me:
1. BIAS - Note the definitive title...No doubt...J&J protects against Delta Vriant
Title:
Johnson & Johnson says COVID-19 vaccine protects against the Delta variant
Actual text: Lots of wiggle words (I have put in CAPS).
Though the analysis was conducted on only a SMALL number of participants and HASN’T YET BEEN PEER-REVIEWED, it SUGGESTS that the Johnson & Johnson vaccine, like the Pfizer and Moderna’s vaccines, MAY provide a buffer for the U.S. against the highly transmissible variant.
Because Moderna’s COVID-19 vaccine is very SIMILAR to Pfizer’s vaccine (they’re both mRNA vaccines), experts think it will LIKELY confer a similar amount of protection. But less was known about how protective Johnson & Johnson’s vaccine would be against the delta variant. Some experts predicted that the Johnson & Johnson vaccine would confer similar protection against delta as the AstraZeneca vaccine because they use the same platform,
And so What about Pfizer...Actually this popped up today...No information about the specific study or if it was peer reviewed...
The Pfizer COVID vaccine is 70 PERCENT effective against the new ultra-contagious Delta variant, claims a new study from the Hebrew University, according to Kan. This is compared to an approximately 95% rate of effectivity of the vaccine against earlier strains of COVID.
According to the study, the Pfizer-BioNTech vaccine is also less effective at preventing people infected with the Delta variant from developing serious symptoms.
Earlier today, Haaretz reports on Health Ministry figures that indicated that the Delta variant is responsible for more than 90% of new COVID cases in Israel over the past two weeks; compared to just 60% of new cases in the country just two weeks ago.
Very sloppy reporting.
Good catch.